Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
复制标题
DOI:
10.18632/oncotarget.17498
复制
发表时间:
2017-07-11
期刊:
影响因子:
--
通讯作者:
Shimizu Y
中科院分区:
文献类型:
--
作者:
Domae E;Hirai Y;Ikeo T;Goda S;Shimizu Y
Vγ9Vδ2 T cells, the major subset of the human peripheral blood γδ T-cell, respond to microbial infection and stressed cells through the recognition of phosphoantigens. In contrast to the growing knowledge of antigen-mediated activation mechanisms, the antigen-independent and cytokine-mediated activation mechanisms of Vγ9Vδ2 T cells are poorly understood. Here, we show that interleukin (IL) -12 and IL-18 synergize to activate human ex vivo-expanded Vγ9Vδ2 T cells. Vγ9Vδ2 T cells treated with IL-12 and IL-18 enhanced effector functions, including the expression of IFN-γ and granzyme B, and cytotoxicity. These enhanced effector responses following IL-12 and IL-18 treatment were associated with homotypic aggregation, enhanced expression of ICAM-1 and decreased expression of the B- and T-lymphocyte attenuator (BTLA), a co-inhibitory receptor. IL-12 and IL-18 also induced the antigen-independent proliferation of Vγ9Vδ2 T cells. Increased expression of IκBζ, IL-12Rβ2 and IL-18Rα following IL-12 and IL-18 stimulation resulted in sustained activation of STAT4 and NF-κB. The enhanced production of IFN-γ and cytotoxic activity are critical for cancer immunotherapy using Vγ9Vδ2 T cells. Thus, the combined treatment of ex vivo-expanded Vγ9Vδ2 T cells with IL-12 and IL-18 may serve as a new strategy for the therapeutic activation of these cells.
登录
查看更多内容
影响因子:
15.3
作者:
Carter, L L;Murphy, K M
通讯作者:
Murphy, K M
DOI:
10.1038/nri2580
发表时间:
2009-07
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.4
作者:
Smeltz, Ronald B.
通讯作者:
Smeltz, Ronald B.
影响因子:
4.4
作者:
Kabelitz, D;Wesch, D;Zöller, M
通讯作者:
Zöller, M
影响因子:
6.6
作者:
Liu, ZY;Guo, BL;Lopez, RD
通讯作者:
Lopez, RD